Irish Agenda: Ciaran Hancock: US clearance for Tysabri will give ...
The Sunday Times - UK
LAST WEEK’S unanimous recommendation by an American advisory panel that Tysabri, Elan’s multiple sclerosis drug, should be cleared again for the market ...

Tysabri EU ruling by summer
Irish Independent - Dublin,Ireland
DRUGMAKER Elan and its research partner Biogen Idec may get a decision on European approval of their multiple sclerosis treatment Tysabri as early as mid-year. ...
See all stories on this topic

Multiple Sclerosis Patients Press US to Clear Tysabri Sales
Bloomberg - USA
March 8 (Bloomberg) -- US regulators are under pressure from multiple sclerosis patients to make Tysabri the second drug to be put back on sale after a safety ...

MS drug Tysabri should return to market-US panel
Reuters.uk - UK
... Maryland (Reuters) - A panel of independent experts on Wednesday unanimously urged the US return of Biogen Idec's multiple sclerosis drug Tysabri, a medicine ...

Tysabri News Lifts Drug Stocks
Forbes - USA
A US Food and Drug Administration advisory panel recommended multiple sclerosis drug Tysabri be allowed back on the market last Wednesday. ...
See all stories on this topic

The Tysabri Game Plan
Forbes - USA
Patient demand may have played a role in an advisory panel's unanimous vote to bring Tysabri back to market, but the fate of the halted multiple sclerosis drug ...